HYDERABAD: Biotechnology firm Bharat Biotech International Ltd has announced the launch of Biohib, the first indigenously developed and manufactured haemophilus influenza type b (HiB) vaccine in India and Comvac 4-hb, a tetravalent combination vaccine. “Biohib is a safe and affordable vaccine that offer complete protection against HiB infection”, a company release said. “Biohib is a conjugate vaccine that has proven its safety and efficacy in multi-centric clinical trials”. The Comvac4-hb and Biohib enable the deployment of a combination pentavalent vaccine in a single injection.